clinical trial

December 2, 2016December 2, 2016

Galapagos Begins Phase 1 Trial of Cystic Fibrosis Corrector in Healthy Volunteers

Cystic Fibrosis, News

Belgium-based Galapagos NV has started its Phase 1 clinical trial evaluating its novel C2 corrector GLPG2737 in healthy volunteers. The drug was developed as part of a triple combination therapy for ... Read more

October 25, 2016October 25, 2016

Phase 3 Trial Data Supports Effectiveness of Ofev in Treating IPF, Regardless of Disease Severity

Idiopathic Pulmonary Fibrosis, News

Analyses of data from two Phase 3 INPULSIS trials support using Ofev (nintedanib) for patients with idiopathic pulmonary fibrosis (IPF). The trials included IPF patients at different disease stages, and revealed that Ofev treatment is ... Read more

October 24, 2016October 24, 2016

FDA Approves Tecentriq Immunotherapy for Specific Type of Advanced Lung Cancer

Lung Cancer, News

The U.S. Food and Drug Administration (FDA) approved Genentech’s Tecentriq (atezolizumab) as a treatment for people with metastatic non-small cell lung cancer (NSCLC). The drug is specifically indicated for NSCLC patients whose ... Read more

October 13, 2016October 13, 2016

Aradigm Partners to Develop Treatments for Resistant Biofilm Lung Infections

Bronchiectasis, Cystic Fibrosis, News

Aradigm Corporation is collaborating with the University of Sydney in Australia to develop nanotechnologies targeting fungal and bacterial biofilms, a common complication of infections associated with chronic diseases like cystic fibrosis ... Read more

August 5, 2016August 5, 2016

Lung Cancer Screenings Not Seen to Cause Undue Stress or Anxiety

News

Lung cancer screening does not cause undue stress according to a clinical trial conducted by British researchers.

August 2, 2016August 2, 2016

Trial Launches to Evaluate Ofev on IPF-Predicting Biomarkers

Idiopathic Pulmonary Fibrosis, News

Boehringer Ingelheim Pharmaceuticals announced the launch of a new clinical trial to investigate the effects of Ofev (nintedanib) on certain blood biomarkers that might help identify fibrosis and loss of lung function ... Read more

July 18, 2016July 18, 2016

Enrollment for Metastatic Non-Small Cell Lung Cancer Trial Cleared by FDA

Lung Cancer, News

BeyondSpring Pharmaceuticals recently announced that the U.S. Food and Drug Administration (FDA) is allowing enrollment in the Phase 1/2 clinical trial to access the company’s drug plinabulin in combination with nivolumab for the treatment of metastatic ... Read more

July 8, 2016July 8, 2016

Nivalis Completes Enrollment in Phase 2 Study of Cystic Fibrosis Therapy

Cystic Fibrosis, News

Nivalis Therapeutics has enrolled the last patient in the larger of two Phase 2 clinical trials evaluating the company’s lead clinical candidate, N91115, for the treatment of cystic fibrosis patients with two faulty copies ... Read more

July 5, 2016July 5, 2016

Cytokinetics Starts Phase 2 Clinical Trial Therapy for COPD Patients

COPD, News

Cytokinetics, a biopharma company that develops muscle activators as potential treatments for certain debilitating diseases, has launched a clinical trial evaluating the efficacy, safety, tolerability, and pharmacokinetics of CK-107 in the ... Read more

July 1, 2016July 1, 2016

New Vaccine Against Pneumococcal Lung Infections Deemed Safe, Triggers Immune Response

News, Pneumonia

A new vaccine against pneumococcal lung infections can safely be used in humans and is able to trigger an immune reaction, reports ImmunoBiology Ltd.